The meeting provided the opportunity to hear from leading JDRF physicians and researchers about progress on everything from the artificial pancreas to islet cell replacement therapy to efforts in prevention. All in all, the two-day event was a remarkable opportunity to see firsthand how JDRF is driving progress in all areas of type 1 diabetes and to reflect on the impact the organization is making and will make in the future.